Drug Therapy in the Elderly

Darrell R. Abernethy

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Scopus citations


This chapter describes drug therapy in the elderly. A hallmark of aging in humans is the development of multiple, coexisting physiological and pathophysiological changes that may benefit from drug therapy. The age-related changes that occur in physiological or psychological function prior to drug exposure are helpful in predicting and describing a particular drug response. The most consistent and predictable age-related change in drug pharmacokinetics (PK) is that of the renal clearance of drugs. Renal function-including renal blood flow, glomerular filtration rate, and active renal tubular secretory processes-declines with increasing age. It has been found that phase II biotransformations are little changed with aging, based on the studies of glucuronidation, sulfation, and acetylation. Prototype substrates studied for glucuronidation have been lorazepam and oxazepam. Theophylline neurotoxicity and cardiotoxicity are increased in older patients. Understanding age-related pathophysiology can, in some instances, allow for the prediction of age-related changes in drug disposition and effect. Drug therapy continues to be a significant contributor to morbidity and mortality in the elderly.

Original languageEnglish (US)
Title of host publicationPrinciples of Clinical Pharmacology
PublisherElsevier Inc.
Number of pages14
ISBN (Print)9780123694171
StatePublished - 2007
Externally publishedYes

ASJC Scopus subject areas

  • Dentistry(all)
  • Medicine(all)


Dive into the research topics of 'Drug Therapy in the Elderly'. Together they form a unique fingerprint.

Cite this